Cholestatic jaundice and IgA nephropathy induced by OTC muscle building agent superdrol

American Journal of Gastroenterology

Volumn 101, Issue 11, 2006, Pages 2659-2662

  Jasiurkowski, Beata ^a   Raj, Jaya ^a   Wisinger, David ^a   Carlson, Richard ^a   Zou, Lixian ^a   Nadir, Abdul ^a  

^a MARICOPA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; CONTRAST MEDIUM; HYDROXYZINE; NON PRESCRIPTION DRUG; SUPERDROL; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ABDOMINAL RADIOGRAPHY; ADULT; ANAMNESIS; ARTICLE; BODY BUILDING; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ERYTHROCYTE TRANSFUSION; FAMILY HISTORY; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; LABORATORY TEST; LIVER BIOPSY; MALE; MUSCLE; OBSTRUCTIVE JAUNDICE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PRURITUS; TREATMENT OUTCOME; URINALYSIS;

ADULT; DIETARY SUPPLEMENTS; GLOMERULONEPHRITIS, IGA; HUMANS; JAUNDICE, OBSTRUCTIVE; MALE; PYRIDINES; TESTOSTERONE; TOLUIDINES;

EID: 33750499534     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00735.x     Document Type: Article

References (14)

1. Wong F. Liver and kidney diseases. Clin Liver Dis 2002;6:981-1011.
2. Endo Y, Kanbayashi H. Etiology of IgA nephropathy syndrome. Pathol Int 1994;44:1-13.
3. Stimac D, Milic S, Dintinjana RD, et al Androgenic/anabolic steroid-induced toxic hepatitis. J Clin Gastroenterol 2002;35:350-2.
4. www.befit.ca/superdrol.html.
5. Carey B. When trust in doctors erodes, other treatment fill the void. N Y Times 2006;53,479:A1 and A20.
6. Caspi O, Koithan M, Criddle MW. Alternative medicine or "alternative" patients: A qualitative study of patient-oriented decision-making processes with respect to complementary and alternative medicine. Med Decis Making 2004;24:64-79.
7. Maravelias C, Dona A, Stefanidou M, et al Adverse effects of anabolic steroids in athletes. A constant threat. Toxicol Lett 2005;158:167-75.
8. Kuhbock J, Radaszkiewicz T, Walek H. [Peliosis hepatis, complicating treatment with anabolic steroids (author's transl)]. Med Klin 1975;70:1602-7.
9. Hepatic effects of 17 alpha-alkylated anaboli-androgenic steroids. HIV Hotline 1998;8:2-5.
10. Ishak KG, Zimmerman HJ. Hepatotoxic effects of the anabolic/androgenic steroids. Semin Liver Dis 1987;7:230-6.
11. Gurakar A, Caraceni P, Fagiuoli S, et al Androgenic/anabolic steroid-induced intrahepatic cholestasis: A review with four additional case reports. J Okla State Med Assoc 1994;87:399-404.
12. Os I, Skjorten F, Svalander C, et al Alpha-1-antitrypsin deficiency associated with hepatic cirrhosis and IgA nephritis. Nephron 1997;77:235-7.
13. Gilboa N, Hopp L, Agostini RM. IgA nephritis in a patient with Alagille syndrome and a transplanted liver. Pediatr Nephrol 1992;6:559-61.
14. Brake MSD, Sondheimer J, Talavera Schmidt R. IgA nephropathy. http://wwwemedicinecom/MED/topic886 2004.